Skip to main content

Tritium , Health Effects and Dosimetry

  • Reference work entry
Encyclopedia of Sustainability Science and Technology

Definition of the Subject

Tritium is a radioactive isotope of hydrogen that is produced both naturally and by man-made activities such as nuclear power plants. As a hydrogen isotope , a tritium atom behaves in the same physical and chemical manner as hydrogen atoms and so it can become part of water molecules and organic molecules. In these forms, tritium is very mobile and can enter biological systems and has the potential to damage living cells.

The biological damage caused by tritium radiation is the same as that from other radiations, but properties such as being an internal risk, being a very weak beta emitter, and being part of organic molecules distinguish its effects from that of other radiations such as x-rays and gamma rays.

Tritium is also distinguished in that it is one of the most studied radioisotopes with respect to causing biological effects. This contribution reviews what is known of the biological effects of tritium...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 6,999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Absorbed dose:

The energy deposited by ionizing radiation to a suitably small volume of matter divided by the mass of that volume. Unit gray, symbol Gy.

Beta particles:

High-energy negatively charged electrons or positively charged positrons that are ejected by radioactive (unstable) elements as they decay. A beta particle is identical in mass and charge to an electron. Beta particles are relatively small and can be stopped, for example, by a sheet of aluminum a few millimeters thick.

Biokinetic model:

A mathematical description of the behavior of radionuclides in the metabolic processes of cells, tissues, organs, and organisms. It is most frequently used to describe distribution of radionuclides among tissues and excretion.

Biological half-life:

Of a given radionuclide, the time required for the activity to decrease, by biological clearance, to half of its original activity.

Carcinogen:

Any agent, such as a chemical or a form of radiation that can cause cancer.

Chromosome:

Structure composed of a very long DNA molecule and associated proteins that carries part (or all) of the hereditary information of an organism.

Chromosome aberrations:

Damage to chromosomes resulting in dicentric chromosomes, centric chromosomes, acentric rings, or terminal deletions.

Chronic exposure:

Exposure persisting in time. The adjective “chronic” relates only to the duration of exposure, and does not imply anything about the magnitude of the doses involved. Normally used to refer to exposures persisting from days to many years.

Deterministic effects:

Changes in cells and tissues that are certain to occur after an acute dose of radiation (in excess of a threshold value of at least 1,000 mSv), below which the radiation effect is not detected. The severity of health effects – such as skin reddening, burns, and hair loss – increase with the radiation dose received.

DNA:

Deoxyribonucleic acid is the molecular compound in the nucleus of a cell that forms the blueprint for the structure and function of the cell. DNA has a three-dimensional structure in which two DNA chains are held together by hydrogen bonding between the bases, forming a helix.

Dose:

A general term for a measure of the energy deposited by radiation in a unit mass. See the more specific terms absorbed dose, equivalent dose, effective dose, and collective dose.

Dose and dose rate effectiveness factor (DDREF):

The ratio between the risk per unit effective dose for high doses and dose rates and low doses and dose rates.

Dose mean lineal energies:

The average or mean energy that is released by the radiant particle along its path. This value is then used to calculate the absorbed dose in Gray.

Dose rate:

A dose delivered over any unit of time (e.g., an annual dose is technically a dose rate).

Dosimetric model:

(1) For intakes of radionuclides into the body, a model that estimates the dose in various organs and tissues per disintegration of a radionuclide in a specified source organ (site of deposition or transit in the body). (2) For external exposure, model that estimates the dose rate in organs and tissues per unit activity concentration of a radionuclide in an environmental medium.

Dosimetry:

A scientific subspecialty in radiation protection and medical physics that focuses on calculating the internal and external doses from ionizing radiation.

Gray (Gy):

Radiation damage is dependent on the absorption of radiation energy and is approximately proportional to the concentration of absorbed energy in tissue. The gray is the SI unit of absorbed radiation dose corresponding to the absorption of 1 Joule (J) of radiation energy per kilogram of material. For gamma and beta radiations, the gray is numerically equal to the sievert.

Hematopoietic:

Any developmental series of cells that derives from hematopoietic stem cells and results in the production of mature blood cells.

Hereditary effect:

A radiation induced health effect that occurs in a descendent of the exposed person.

In vitro:

Latin for “within the glass,” a term used to describe experiments that are performed not in a living organism but in a controlled environment, such as in a test tube or Petri dish.

In vivo:

Latin for “within the living,” a term used to describe experiments using a whole, living organism as opposed to a partial or dead organism, or an in vitro controlled environment.

Internal emitter:

A radioactive substance that has entered the body through ingestion, inhalation, or absorption.

Isotropic effect:

The difference in physical properties and chemical reactivity due to the difference in mass between isotopes of the same element.

Linear energy transfer:

A measure of energy deposited over a distance as the energy is transferred from radiation to the exposed matter. A high value of linear energy transfer indicates that energy is deposited within a small distance (i.e., Joules μm−1).

Oocyte:

The developing egg. It is usually a large and immobile cell.

Oogenesis:

Formation and maturation of oocytes in the ovary.

Orthovoltage x-rays:

X-rays produced by x-ray tubes operating at voltages in the 200–500 kVp range (i.e., the peak voltage), and thus possessing energy up to 200–500 keV, although there is a spectrum of energies with a peak much less than the peak tube voltage.

Relative biological effectiveness (RBE):

A relative measure of the effectiveness of different radiation types in inducing a specified health effect. It is expressed as the inverse ratio of the absorbed doses of two different radiation types, the denominator being the reference radiation that would produce the same degree of a defined biological end point.

Stochastic effects:

A term used to group radiation induced health effects that have a statistical risk, such as cancer or inheritable diseases. For these diseases, the probability of their occurrence increases proportionally to the radiation dose received: the lower the dose, the lower the probability of occurrence. However, at no time, even for high doses, is it certain that cancer or genetic damage will result.

Teratogenic:

Substances or agents that can interfere with normal embryonic development.

Tritium:

A radioactive isotope of the element hydrogen (symbol T or 3H). The nucleus of tritium (sometimes called a triton) contains one proton and two neutrons. Tritium atoms can replace hydrogen atoms in water molecules to form tritiated water (HTO), in organic molecules to form organically bound tritium (OBT), in air to form tritiated gas (HT). Tritium also exists in many other compounds such as tritiated hydrocarbons, tritiated particulates, tritiated thymidine, and metal tritides (tritium bearing metals).

X-ray:

Ionizing electromagnetic radiation emitted by an atom when it has been bombarded with electrons. X-rays differ from gamma rays in that they are emitted from the orbiting electrons, not the nucleus, and they have a much wider energy range, or spectra. A “soft X-ray” is one of low energy, generally below 100 keV.

Bibliography

  1. Carsten AL (1979) Tritium in the environment: isotopic effects and transmutation. In: Lett JT, Adler H (eds) Advances in radiation biology. Academic, New York

    Google Scholar 

  2. Virsik RP, Schäfer CH, Harder D (1980) Chromosome aberrations induced in human lymphocytes by ultrasoft AlK and CK X-rays. Int J Radiat Biol 38(5):545–557

    Article  CAS  Google Scholar 

  3. Pinson EA, Langham WH (1957) Physiology and toxicology of tritium in Man. J Appl Physiol 10:108–126

    CAS  Google Scholar 

  4. DeLong CW, Thompson RC, Kornberg HA (1954) Percutaneous absorption of tritium oxide. Am J Roentgenol Radium Ther Nucl Med 71:1038–1045

    CAS  Google Scholar 

  5. International Commission on Radiological Protection (ICRP) (1975) Report of the task group on reference man. ICRP Publication 23. Pergamon, New York

    Google Scholar 

  6. Belloni P, Clemente GF, Di Piero S, Ingrao G (1983) Tritium levels in blood and urine samples of the members of the Italian general population and some exposed subjects. Radiat Prot Dosim 4:109–113

    CAS  Google Scholar 

  7. Hill RL, Johnson JR (1993) Metabolism and dosimetry of tritium. Health Phys 65(6):628–647

    Article  CAS  Google Scholar 

  8. National Council on Radiation Protection and Measurements (NCRP) (1979) Tritium and other radionuclide labelled organic compounds incorporated into genetic material. Report No. 63 U.S. NCRP, Washington, DC

    Google Scholar 

  9. Amano H, Atarashi M, Noguchi H, Yokoyama S (1995) Formation of organically bound tritium in plants during the 1994 chronic HT release experiment at Chalk River. Fusion Technol 28:814–820

    Google Scholar 

  10. Rochalska M, Szot Z (1977) The incorporation of organically-bound tritium of food into some organs of the rat. Int J Radiat Biol 31(4):391–395

    Article  CAS  Google Scholar 

  11. Saito M, Ishida MR (1989) Dose-modification factor for accumulated dose to cell nucleus due to protein-bound H-3. Health Phys 56:869–874

    Article  CAS  Google Scholar 

  12. Diabaté S, Strack S (1993) Organically bound tritium. Health Phys 65(6):698–712

    Article  Google Scholar 

  13. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (2008) United Nations. Effects of ionizing radiation. Volume II, Annex C – Non-targeted and delayed effects of exposure to ionizing radiation. 2006 Report to the General Assembly, with scientific annexes. United Nations, New York

    Google Scholar 

  14. Persaud R, Zhou H, Baker SE, Hei TK, Hall EJ (2005) Assessment of low linear energy transfer radiation-induced bystander mutagenesis in a three-dimensional culture model. Cancer Res 65:9876–9882

    Article  CAS  Google Scholar 

  15. Rodgers DW (1992) Tritium dynamics in mice exposed to tritiated water and diet. Health Phys 63:331–337

    Article  CAS  Google Scholar 

  16. Richmond CR, Langham WH, Trujillo TT (1962) Comparative metabolism of tritiated water by mammals. J Cell Comp Physiol 59:45–53

    Article  CAS  Google Scholar 

  17. Brues AM, Stroud AN, Rietz L (1952) Toxicity of tritium oxide to mice. Proc Soc Exp Biol Med 79(1):174–176

    CAS  Google Scholar 

  18. Furchner JE (1957) Relative biological effectiveness of tritium beta-particles and cobalt 60 gamma-rays measured by lethality in CF1 mice. Radiat Res 6:483–490

    Article  CAS  Google Scholar 

  19. Yokoro K, Yamamoto O, Seyama T, Kinomura A (1986) Acute and chronic effects of tritiated water in mice with special reference to its carcinogenicity: an interim report. Radiat Prot Dosim 16:165–168

    CAS  Google Scholar 

  20. Yamamoto O, Yokoro T, Seyama A, Kinomura T (1990) HTO oral administration in mice. I: threshold dose rate for haematopoietic death. Int J Radiat Biol 57(3):543–549

    Article  CAS  Google Scholar 

  21. Soloviev V, Ilyin LA, Baranov AE et al (2001) In: Gusev IA, Guskova AK, Mettler FA (eds) Medical management of radiation accidents, 2nd edn. CRC Press, Boca Raton, pp 46 and 158

    Google Scholar 

  22. Melintescu A, Galeriu D, Takeda H (2007) Reassessment of tritium dose coefficients for the general public. Radiat Prot Dosim 127(1–4):153–157

    Article  CAS  Google Scholar 

  23. National Research Council (NRC) (1980) The effects on populations of exposure to low levels of ionizing radiation. The committee on the biological effects of ionizing radiations (BEIR III). The National Academies Press, Washington, DC

    Google Scholar 

  24. National Research Council (NRC) (2006) Health Risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Board on radiation effects research. The committee on the biological effects of ionizing radiations (BEIR). The National Academies Press, Washington, DC

    Google Scholar 

  25. Straume T, Carsten AL (1993) Tritium radiobiology and relative biological effectiveness. Health Phys 65(6):657–672

    Article  CAS  Google Scholar 

  26. Commerford SL, Carsten AL, Cronkite EP (1982) The turnover of tritium in cell nuclei, chromatin, DNA, and histone. Radiat Res 92:521–529

    Article  CAS  Google Scholar 

  27. Health Protection Agency (HPA) (2007) Review of risks from tritium with particular attention to tritiated water and organic compounds containing tritium. Report of AGIR subgroup on tritium risks, UK advisory group on ionizing radiation. http://www.hpa.org.uk/radiation/advisory_groups/agir/index.htm

  28. Brown RM (1995) The measurement of tritium in Canadian food items. Atomic Energy Control Board (now the Canadian Nuclear Safety Commission) AECB INFO 0499. Atomic Energy Control Board, Ottawa

    Google Scholar 

  29. Dekaban AS (1968) Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. Int J Nucl Med 9(9):471–477

    CAS  Google Scholar 

  30. Mulvihill JJ, Harvey EB, Boice JD Jr, Chakravarti A, Miller RW (1991) Normal findings 52 years after in utero radiation exposure. Lancet 338(8776):1202–1203

    Article  CAS  Google Scholar 

  31. Zamenhof S, van Martheus E (1979) The effects of chronic ingestion of tritiated water on the prenatal brain development. Radiat Res 77:117–127

    Article  CAS  Google Scholar 

  32. Laskey JW, Pamsh JL, Cahill DF (1973) Some effects of lifetime parental exposure to low levels of tritium on the F2 generation. Radiat Res 56(17):1–179

    Google Scholar 

  33. Bursian SJ, Cahill DF, Laskey JW, Parker LN (1975) Some aspects of brain neurochemistry after intrauterine exposure to tritium. Int J Radiat Biol Relat Stud Phys Chem Med 27(5):455–461

    Article  CAS  Google Scholar 

  34. Jones DC, Krebs JS, Sasmore DP, Mitoma C (1980) Evaluation of neonatal squirrel monkeys receiving tritiated water throughout gestation. Radiat Res 83(3):592–606

    Article  CAS  Google Scholar 

  35. Dobson RL, Cooper MF (1974) Tritium toxicity: effects of low-level 3HOH exposure on developing female germ cells in the mouse. Radiat Res 58:91–100

    Article  CAS  Google Scholar 

  36. Dobson RL, Kwan TC (1976) The RBE of tritium radiation measured in mouse oocytes: increase at low exposure levels. Radiat Res 66:615–625

    Article  CAS  Google Scholar 

  37. Lushbaugh CC, Ricks RC (1972) Some cytokinetic and histopathologic considerations of irradiated male and female gonadal tissues. In: Vaeth JM (ed) Frontiers of radiation therapy and oncology, vol 6. Karger, Basel, pp 228–248

    Google Scholar 

  38. Lushbaugh CC, Casarett GW (1976) The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 37(2 Suppl):1111–1125

    Article  CAS  Google Scholar 

  39. Baker TG, Neal P (1977) Action of ionizing radiations on the mammalian ovary. In: Zuckerman S, Weir BJ (eds) The ovary, vol 3. Academic, New York

    Google Scholar 

  40. United Nations Scientific Committee on the effects of ionising radiation (UNSCEAR) (1982) Ionising radiation: sources and biological effects, Vienna

    Google Scholar 

  41. Baker TG (1971) Comparative aspects of the effects of radiation during oogenesis. Mutat Res 11:9–22

    Article  CAS  Google Scholar 

  42. International Commission on Radiological Protection (ICRP) (1984) A compilation of the major concepts and quantities in use by the ICRP. ICRP Publication 42. Ann ICRP 14(4). Pergamon, New York

    Google Scholar 

  43. National Research Council (NRC) (1990) Health risks from exposure to low levels of ionizing radiation. The committee on the biological effects of ionizing radiations BEIR V. National Academies Press, Washington, DC

    Google Scholar 

  44. Satow Y, Hori H, Lee J-Y, Ohtaki M, Sawada S, Nakamura N, Okada S (1989) Effect of tritiated water on female germ cells: mouse oocytes killing and RBE. Int J Radiat Biol 56(3):293–299

    Article  CAS  Google Scholar 

  45. Satow Y, Hori H, Lee J-Y (1989) Teratogenic effect of fission neutron and tritium water on rat embryo. J UOEH 11(Suppl):416–431

    CAS  Google Scholar 

  46. Oakberg EF (1955) Sensitivity and time of degeneration of spermatogenic cells irradiated in various stages of maturation in the mouse. Radiat Res 2:369–391

    Article  CAS  Google Scholar 

  47. Oakberg EF (1959) Initial depletion and subsequent recovery of spermatogonia of the mouse after 20 R of gamma rays and 100, 300, and 600 R of x-rays. Radiat Res 11:700–719

    Article  CAS  Google Scholar 

  48. Oakberg EF, Clark E (1964) Species comparison of radiation response of the gonads. In: Carlson WD, Gaffner FX (eds) Effects of ionizing radiation on the reproductive system. Pergamon, Oxford, pp 11–24

    Google Scholar 

  49. Lambert BE (1969) Cytological damage produced in the mouse testes by tritiated thymidine, tritiated water and X-rays. Health Phys 17:547–557

    Article  CAS  Google Scholar 

  50. National Research Council (NRC) (1988) Health risks of radon and other internally deposited alpha-emitters. The committee on the biological effects of ionizing radiations (BEIR IV). National Academy Press, Washington, DC

    Google Scholar 

  51. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (2000) United Nations. Sources and effects of ionizing radiation, vol I: sources; vol II: effects. Report to the General Assembly, with scientific annexes. United Nations sales publication E.00.IX.3 and E.00.IX.4. United Nations, New York

    Google Scholar 

  52. Tanaka IB, Tanaka S, Ichinohe K, Matsushita S, Matsumoto T, Otsu H, Oghiso Y, Sato F (2007) Cause of death and neoplasia in mice continuously exposed to very low dose rates of gamma rays. Radiat Res 167(4):417–437

    Article  CAS  Google Scholar 

  53. Yamamoto O, Seyama T, Jo T, Terato H, Saito T, Kinomura A (1995) Oral administration of tritiated water (HTO) in mouse. II. tumour development: I/II/III. Int J Radiat Biol 68(1):47–54

    Article  Google Scholar 

  54. Yamamoto O, Seyama T, Itoh H, Fujimoto N (1998) Oral administration of tritiated water (HTO) in mouse. III: low dose-rate irradiation and threshold dose-rate for radiation risk. Int J Radiat Biol 73(5):535–541

    Article  CAS  Google Scholar 

  55. Gragtmans NJ, Myers DK, Johnson JR, Jones AR, Johnson LD (1984) Occurrence of mammary tumors in rats after exposure to tritium beta rays and 200 kVp x-rays. Radiat Res 99(3):636–650

    Article  CAS  Google Scholar 

  56. Johnson JR, Myers DK, Jackson JS, Dunford DW, Gragtmans NJ, Wyatt HM, Jones AR, Percy DH (1995) Relative biological effectiveness of tritium for induction of myeloid leukemia in CBA/H mice. Radiat Res 144(1):82–89

    Article  CAS  Google Scholar 

  57. Seyama T, Yamamoto O, Kinomura A, Yokoro K (1991) Carcinogenic effects of tritiated water (HTO) in mice: in comparison to those of neutrons and gamma-rays. J Radiat Res 32(Supp 2):132–142

    Article  Google Scholar 

  58. Balonov MI, Muksinova KN, Mushkacheva GS (1993) Tritium radiobiological effects in mammals: review of experiments in the last decade in Russia. Health Phys 65(6):713–726

    Article  CAS  Google Scholar 

  59. Mushkacheva GS, Rusinova GG, Muskinova KN, Lemberg VK, Shorokhova VB, Revina VS, Uryadnitskaya TI (1992) In: Buldakov L (ed) Genetic structures and tritium. Energoatomizdat, Moscow (in Russian)

    Google Scholar 

  60. Straume T (1993) Tritium risk assessment. Health Phys 65(6):673–682

    Article  CAS  Google Scholar 

  61. International Commission on Radiological Protection (ICRP) (1991) 1990 recommendations of the international commission on radiological protection. ICRP Publication 60, Ann ICRP 21(1-3):1–201. Pergamon, Oxford

    Google Scholar 

  62. United Nations Scientific Committee on the effects of ionising radiation (UNSCEAR) (1988) Sources, effects and risks of ionizing radiation, Vienna

    Google Scholar 

  63. International Commission on Radiological Protection (ICRP) (2007) Recommendations of the ICRP. IRCP Publication 103. Ann ICRP 37(2–4). Pergamon, Oxford

    Google Scholar 

  64. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (2001) Hereditary effects of radiation. Report to the General Assembly, with Scientific Annex. United Nations, New York

    Google Scholar 

  65. Furuno-Fukushi I, Ueno AM, Matsudaira H (1987) Cell killing and mutation to 6-thioguanine resistance after exposure to tritiated amino acids and tritiated thymidine in cultured mammalian cells (L5178Y). Radiat Res 110:428–438

    Article  CAS  Google Scholar 

  66. Ueno AM, Furuno-Fukushi I, Matsudaira H (1982) Induction cell killing, micronuclei, and mutation to 6-thioguanine resistance after exposure to low-dose-rate γ rays and tritiated water in cultured mammalian cells (L5178Y). Radiat Res 91:447–456

    Article  CAS  Google Scholar 

  67. Wang B, Watanabe K, Yamada T, Takeshi S, Shima A (1996) Effects of beta radiation from organically bound tritium on cultured mouse embryonic mid brain cells. Health Phys 71(6):915–921

    Article  CAS  Google Scholar 

  68. Trivedi A, Morrison DP, Gentner NE (1997) Relative biological effectiveness for organically bound tritium. Health Phys 73(2):397–398

    CAS  Google Scholar 

  69. Steel GG, Lamerton LF (1965) The turnover of tritium from thymidine in tissues of the rat. Exp Cell Res 37:117–123

    Article  CAS  Google Scholar 

  70. Lambert BE, Clifton RJ (1968) Radiation doses resulting from the ingestion of tritiated thymidine by the rat. Health Phys 15:3–9

    Article  CAS  Google Scholar 

  71. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res 160:381–407

    Article  CAS  Google Scholar 

  72. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K (2004) Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 162:377–389

    Article  CAS  Google Scholar 

  73. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168(1):1–64

    Article  CAS  Google Scholar 

  74. Boice JD Jr, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, Clarke EA, Coleman MP et al (1985) Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74:955–975

    Google Scholar 

  75. Boice JD Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC et al (1988) Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116:3–55

    Article  Google Scholar 

  76. Weiss HA, Darby SC, Doll R (1994) Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 59:327–338

    Article  CAS  Google Scholar 

  77. Weiss HA, Darby SC, Fearn T, Doll R (1995) Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res 142:1–11

    Article  CAS  Google Scholar 

  78. Howe GR (1995) Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res 142:295–304

    Article  CAS  Google Scholar 

  79. Howe GR, McLaughlin J (1996) Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 145:694–707

    Article  CAS  Google Scholar 

  80. Little MP, Weiss HA, Boice JD Jr, Darby SC, Day NE, Muirhead CR (1999) Risks of in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res 152(3):280–292

    Article  CAS  Google Scholar 

  81. Little MP, Boice JD Jr (1999) Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151:218–224

    Article  CAS  Google Scholar 

  82. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe GR, Kunz E et al (1995) Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst 87(11):817–827

    Article  CAS  Google Scholar 

  83. Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, Fry SA, Kaldor J, Lave C, Salmon L, Smith PG, Voelz GL, Wiggs LD (1995) Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117–132

    Article  CAS  Google Scholar 

  84. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Solano JB, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklof M, Engels H, Engholm G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K (2005) Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. Br Med J 331(7508):77

    Article  CAS  Google Scholar 

  85. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR et al (2007) The 15 country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 167(4):396–416

    Article  CAS  Google Scholar 

  86. Canadian Nuclear Safety Commission (2009) Tritium releases and dose consequences in Canada in 2006. Part of the tritium studies project INFO-0793

    Google Scholar 

  87. Durham Region Health Department (2007) Radiation and health in Durham region. Durham Region Health Department, Oshawa

    Google Scholar 

  88. Evrard A-S, Hemon D, Morin A, Laurier D, Tirmarche M, Backe J-C, Cartier M, Clavel J (2006) Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates. Br J Cancer 94(9):1342–1347

    Article  Google Scholar 

  89. Grosche B, Lackland D, Mohr L, Dunbar J, Nicholas J, Burkart W, Hoel D (1999) Leukaemia in the vicinity of two tritium-releasing nuclear facilities: a comparison of the Kruemmel Site, Germany, and the Savannah River Site, South Carolina, USA. J Radiol Prot 19:243–252

    Article  CAS  Google Scholar 

  90. Jablon S, Hrubec Z, Boice JD Jr (1991) Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. J Am Med Assoc 265(11):1403–1408

    Article  CAS  Google Scholar 

  91. Sever LE, Hessol NA, Gilbert ES, McIntyre JM (1988) The prevalence at birth of congenital malformations in communities near the Hanford site. Am J Epidemiol 127(2):243–254

    CAS  Google Scholar 

  92. Spix C, Schmiedel S, Kaatsch P, Schulze-Rath R, Blettner M (2008) Case-control study on childhood cancer in the vicinity of nuclear power plants in Germany 1980–2003. Eur J Cancer 44(2):275–284

    Article  Google Scholar 

  93. Kaatsch P, Spix C, Schulze-Rath R, Schmiedel S, Blettner M (2008) Leukaemia in young children in the vicinity of German nuclear power plants. Int J Cancer 122(4):721–726

    Article  CAS  Google Scholar 

  94. Laurier D, Hemon D, Clavel J (2008) Childhood leukaemia incidence below the age of 5 years near French nuclear power plants. J Res Pract 28:401–403

    CAS  Google Scholar 

  95. Bithell JF, Keegan TJ, Kroll ME, Murphy FG, Vincent TJ (2008) Childhood leukaemia near British nuclear installations: methodological issues and recent results. Radiat Prot Dosim 132(2):191–197

    Article  CAS  Google Scholar 

  96. Grosche B (2008) The “Kinderkrebs in der umgerbung von kernkraftwerken” study: results put into perspective. Radiat Prot Dosim 132(2):198–201

    Google Scholar 

  97. SSK (German Radiological Protection Commission) (2008) Assessment of the “Epidemiological Study on Childhood Cancer in the Vicinity of Nuclear Power Plants” (KiKK Study): position of the commission on radiological protection (SSK). SSK, Bonn

    Google Scholar 

  98. Beral V, Fraser P, Carpenter L, Booth M, Brown A, Rose G (1988) Mortality of employees of the atomic weapons establishment, 1951–82. Br Med J 297:757–770

    Article  CAS  Google Scholar 

  99. Cragle DL, Watkins JP, Robertson-DeMers K (1998) Mortality among workers at the Savannah River nuclear fuels production facility. In: ASA 1998 proceedings of the section on statistics in epidemiology. American Statistical Association, Alexandria, pp 83–87. http://www.orau.gov/ehsd/EpiProceedings-jj-9-30-98.doc

  100. Johnson P, Atkinson WD, Nicholls JL (1999) Updated analysis of mortality in workers at UK atomic weapons establishments. In: Proceedings of the SRP sixth international symposium: achievements & challenges: advancing radiation protection into the 21st century, Southport

    Google Scholar 

  101. Zablotska LB, Ashmore JP, Howe GR (2004) Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat Res 161:633–641

    Article  CAS  Google Scholar 

  102. Schubauer-Berrigan MK, Daniels RD, Fleming DA, Markey AM, Couch JR, Ahrenholz SH, Burphy JS, Anderson JL, Tseng C-Y (2007) Risk of chronic myeloid and acute leukemia mortality after exposure to ionizing radiation among workers at four U.S. nuclear weapons facilities and a nuclear naval shipyard. Radiat Res 167:222–232

    Article  Google Scholar 

  103. Richardson DB, Wing S (2007) Leukemia mortality among workers at the Savannah River Site. Am J Epidemiol 166(9):1015–1022

    Article  Google Scholar 

  104. Hazelton WD, Suresh MH, Curtis SB, Zielinski JM, Ashmore PJ, Krewski D (2006) Biologically based analysis of lung cancer incidence in a large Canadian occupational cohort with low-dose ionizing radiation exposure, and comparison with Japanese atomic bomb survivors. J Toxicol Environ Health A 69:1013–1038

    Article  CAS  Google Scholar 

  105. Laurier D, Grosche B, Hall P (2002) Risk of childhood leukemia in the vicinity of nuclear installations – findings and recent controversies. Acta Oncol 41(1):14–24

    Article  Google Scholar 

  106. Committee Examining Radiation Risks of Internal Emitters (CERRIE) (2004) Final report [downloaded 20 October 2004]. http://www.cerrie.org/report/

  107. Cox R, Menzel H-G, Preston J (2008) Invited editorial: internal dosimetry and tritium – the ICRP position. J Res Pract 28(2):131–135

    Google Scholar 

  108. Kacena V (1967) Chemical effects of decay of incorporated radioisotopes. In: Proceedings of the conference on biological effects of transmutation and decay of incorporated radioisotopes. IAEA, Vienna, pp 199–214

    Google Scholar 

  109. Myers DK, Johnson JR (1991) Toxicity and dosimetry of tritium: a review. Atomic Energy Control Board (now the Canadian Nuclear Safety Commission), Ottawa; Advisory Committee on Radiological Protection; INFO-0377

    Google Scholar 

  110. Feinendegen LE, Bond VP (1971) Transmutation versus beta irradiation in the pathological effects of tritium decay. In: Moghissi AA, Carter MW (eds) Tritium. Messenger Graphics, Nevada, pp 221–232

    Google Scholar 

  111. Little MP, Lambert BE (2008) Systematic review of experimental studies of relative biological effectiveness of tritium. Radiat Environ Biophys 47(1):71–93

    Article  CAS  Google Scholar 

  112. Prosser JS, Lloyd DC, Edwards AA, Stather JW (1983) The induction of chromosome aberrations in human lymphocytes by exposure to tritiated water. Radiat Prot Dosim 4(1):21–26

    Google Scholar 

  113. Carsten AL, Commerford SL (1976) Dominant lethal mutations in mice resulting from chronic tritiated water (HTO) ingestion. Radiat Res 66:609–614

    Article  CAS  Google Scholar 

  114. Russell WL, Cumming RB, Kelly EM, Phipps EL (1979) Induction of specific-locus mutations in the mouse by tritiated water. In: Behaviour of tritium in the environment. In: Proceedings of a symposium on the behaviour of tritium in the environment, 16 Oct 1978, San Francisco, IAEA-SM-232/85. IAEA, Vienna, pp 489–497

    Google Scholar 

  115. Lloyd DC, Purrott RJ, Dolphin GW, Bolton D, Edwards AA (1975) The relationship between chromosome aberrations and low LET radiation dose to human lymphocytes. Int J Radiat Biol 28:75–90

    Article  CAS  Google Scholar 

  116. Chopra C, Heddle JA (1988) Cytogenetic measurements of the relative biological effectiveness of tritium. Report INFO-0287. Atomic Energy Control Board (now the Canadian Nuclear Safety Commission), Ottawa

    Google Scholar 

  117. Kocher DC, Apostoaei AI, Hoffman FO (2005) Radiation effectiveness factors for use in calculating probability of causation of radiogenic cancers. Health Phys 89(1):3–32

    Article  CAS  Google Scholar 

  118. Environment Canada (EC), Health Canada (HC) (PSL2) (2003) Releases of radionuclides from nuclear facilities (impact on non-human biota). Canadian Environmental Protection Act, 1999, Priority substances list assessment report. Environment Canada, Ottawa

    Google Scholar 

  119. International Commission on Radiation Units and Measurements (ICRU) (1970) Linear energy transfer. ICRU Report 16, Bethesda

    Google Scholar 

  120. Nikjoo H, Goodhead DT (1991) Track structure analysis illustrating the prominent role of low energy electrons in radiobiological effects of low-LET radiations. Phys Med Biol 36:229–238

    Article  CAS  Google Scholar 

  121. Chen J (2006) Radiation quality of tritium. Radiat Prot Dosim 122(1–4):546–548

    Google Scholar 

  122. Cheng YS, Snipes MB, Kropf RF, Jow HN (1995) Radiation dosimetry of metal tritides. Health Phys 68(Suppl 6):S53

    Google Scholar 

  123. Cheng YS, Snipes MB, Wang Y, Jow HN (1999) Biokinetics and dosimetry of titanium tritide particulates in the lung. Health Phys 76(2):120–128

    Article  CAS  Google Scholar 

  124. Cheng YS, Zhou Y, Wang Y, Inkret WC, Wermer JR, Joseph R (2002) Dose estimate of inhaled hafnium tritide using the ICRP 66 lung model. Health Phys 82(6):817–824

    Article  CAS  Google Scholar 

  125. International Commission on Radiological Protection (ICRP) (1995) Age-dependent doses to members of the public from intakes of radionuclides: part 4, inhalation dose coefficients. Publication 71, 25(3–4). Pergamon, Oxford

    Google Scholar 

  126. Richardson RB, Hong A (2001) Dose to lung from inhaled tritiated particles. Health Phys 81(3):313–324

    Article  CAS  Google Scholar 

  127. International Commission on Radiological Protection (ICRP) (1989) Age-dependent doses to members of the public from intake of radionuclides: part 1. ICRP Publication 56. Ann ICRP 20(2). Pergamon, Oxford

    Google Scholar 

  128. International Commission on Radiological Protection (ICRP) (1993) Age-dependent doses to members of the public from intake of radionuclides: part 2. ICRP Publication 67. Ann ICRP 23(3/4). Pergamon, Oxford

    Google Scholar 

  129. Health and Welfare Canada (1983) Bioassay guideline 2 – guidelines for tritium bioassay, Report of the working group on bioassay and in vivo monitoring criteria, Environmental Health Directorate, 83-EHD-87

    Google Scholar 

  130. Canadian Nuclear Safety Commission (2005) Radiobioassay and dose assessment for intakes of tritium, Report of the CNSC working group on internal dosimetry, RPS-0182B, Radiation Index

    Google Scholar 

  131. Atomic Energy Control Board (now the Canadian Nuclear Safety Commission) (1987) The determination of effective doses from the intake of tritiated water. Regulatory Policy Statement R-100

    Google Scholar 

  132. Johnson JR (1982) The estimation of the effective dose equivalent from tritiated water exposures using tritium concentrations in urine. Radiat Prot Dosim 2:245–247

    CAS  Google Scholar 

  133. International Commission on Radiological Protection (ICRP) (1995) Basic anatomical and physiological data for use in radiological protection: the skeleton. Publication 70, 25(2). Pergamon, Oxford

    Google Scholar 

  134. International Commission on Radiological Protection (ICRP) (1979–1982) Limits for intakes of radionuclides by workers, ICRP Publication 30, Part 1 (and Supplement), Part 2 (and Supplement), Part 3 (and Supplements A and B), and Index, prepared by Committee 2, adopted by the Commission in July 1978, Annals of the ICRP. Pergamon, New York

    Google Scholar 

  135. Trivedi A, Galeriu D, Richardson RB (1997) Dose contribution from metabolized organically bound tritium after acute tritiated water intakes in humans. Health Phys 73(4):579–586

    Article  CAS  Google Scholar 

  136. Trivedi A, Galeriu D, Lamothe ES (2000) Dose contribution from metabolized OBT after chronic tritiated water intakes in humans. Health Phys 78(1):2–7

    Article  CAS  Google Scholar 

  137. Osborne RV (1966) Absorption of tritiated water by people. Health Phys 12:1527–1537

    Article  CAS  Google Scholar 

  138. Peterman BF, Johnson JR, McElroy RGC (1985) HT/HTO conversion in mammals. Fusion Technol 8:2557–2563

    CAS  Google Scholar 

  139. International Commission on Radiological Protection (ICRP) (1994) Human respiratory tract model for radiological protection. Publication 66, 24(1–3). Pergamon, Oxford

    Google Scholar 

  140. Phipps AM, Kendall GW, Fell TP, Harrison JD (1990) Doses from radioactive methane. Radiat Prot Dosim 30:191–195

    CAS  Google Scholar 

  141. International Commission on Radiological Protection (ICRP) (1996) Age-dependent doses to members of the public from intake of radionuclides: part 5. ICRP Publication 72. Ann ICRP 26(1). Pergamon, Oxford

    Google Scholar 

  142. International Commission on Radiological Protection (ICRP) (2001) Doses to the embryo and fetus from intakes of radionuclides by the mother. Publication 88, 31(1–3). Pergamon, Oxford

    Google Scholar 

  143. International Commission on Radiological Protection (ICRP) (2004) Doses to infants from ingestion of radionuclides in mothers’ milk. ICRP Publication 95, 34(3–4). Pergamon, Oxford

    Google Scholar 

  144. Butler HC, Leroy JH (1965) Observation of biological half-life of tritium. Health Phys 11:283–285

    Article  CAS  Google Scholar 

  145. Rudran K (1988) Significance of in vivo organic binding of tritium following intake of tritiated water. Radiat Prot Dosim 25(1):5–13

    CAS  Google Scholar 

  146. Balonov MI, Dolgirev EI, Likhtarev IA (1974) Exchange kinetics and dosimetry of tritium oxide in man for different routes of administration. Health Phys 27(4):367–375

    Article  CAS  Google Scholar 

  147. Foy JM, Schneiden H (1960) Estimation of total body water (virtual tritium space) in the rat, cat, rabbit, guinea-pig and man, and of the biological half-life of tritium in man. J Physiol 154:169–176

    CAS  Google Scholar 

  148. Wylie KF, Bigler WA, Grove GR (1963) Biological half-life of tritium. Health Phys 9:911–914

    Article  CAS  Google Scholar 

  149. Snyder WS, Fish BR, Bernard SR, Ford MR, Muir JR (1968) Urinary excretion of tritium following exposure of man to HTO – a two exponential model. Phys Med Biol 13:547–559

    Article  CAS  Google Scholar 

  150. Sanders SM Jr, Reinig WC (1968) Assessment of tritium in man. In: Diagnosis and treatment of deposited radionuclides. Excerpta Medica Foundation, Amsterdam, pp 534–542

    Google Scholar 

  151. Minder W (1969) Internal contamination with tritium. Strahlentherapie 137:700–704

    CAS  Google Scholar 

  152. Lambert BE, Sharp HBA, Dawson KB (1971) An accidental intake of tritiated water. Am Ind Hyg Assoc J 32:682–686

    Article  CAS  Google Scholar 

  153. Moghissi AA, Carter MW, Lieberman R (1971) Long-term evaluation of the biological half-life of tritium. Health Phys 21:57–60

    Article  CAS  Google Scholar 

  154. Moghissi AA, Carter MW, Lieberman R (1972) Further studies on the long-term evaluation of the biological half-life of tritium. Health Phys 23:805–806

    Article  CAS  Google Scholar 

  155. Bennet BG (1972) The radiation dose due to acute intake of tritium in man. USAEC Report, HASL-253

    Google Scholar 

  156. Trivedi A, Richardson RB, Galeriu D (1994) Dose from organically bound tritium after an acute tritiated water intake in humans. Atomic Energy Control Board (Canada) Research Report INFO-0598

    Google Scholar 

  157. Taylor DM (2003) A biokinetic model for predicting the retention of 3H in the human body after intakes of tritiated water. Radiat Prot Dosim 105:225–228

    Article  CAS  Google Scholar 

  158. Takeda H, Kasida Y (1979) Biological behavior of tritium after administration of tritiated water in the Rat. J Radiat Res 20:174–185

    Article  CAS  Google Scholar 

  159. International Commission on Radiological Protection (ICRP) (1959) Recommendations of the international commission on radiological protection: report of committee II. ICRP Publication 2. Pergamon, London

    Google Scholar 

  160. Ichimasa Y, Ichimasa M, Shiba T, Oda M, Akita Y (1986) Fixation of tritium gas by rats. Radiat Prot Dosim 16:127–130

    CAS  Google Scholar 

  161. International Commission on Radiological Protection (ICRP) (1994) Dose coefficients for intakes of radionuclides by workers. Publication 68, 24(4). Pergamon, Oxford

    Google Scholar 

  162. Trivedi A, Gentner NE (1999) Dosimetry and health effects of tritium, AECL RC-2243. AECL, Chalk River

    Google Scholar 

  163. Eakins JD, Hutchinson WP, Lally AE (1975) The radiological hazard from tritium sorbed on metal surfaces. Health Phys 28(3):213–224

    Article  CAS  Google Scholar 

  164. Johnson JR, Dunford DW (1985) Dosimetric models of 3H from skin absorption following contact with T2-contaminated surfaces. Health Phys 48(1):110–113

    CAS  Google Scholar 

  165. Trivedi A, Cornett RJ, Galeriu D, Workman W, Brown RM (1997) Daily tritium intakes by people living near a heavy-water research reactor facility: dosimetric significance. AECL-11648, COG-96-333-I

    Google Scholar 

  166. Richardson RB, Trivedi A, Greenstock CL (1998) Dosimetry of organically bound tritium derived from diet – phase 1. AECB RSP-068

    Google Scholar 

  167. Richardson RB (2001) Dosimetry of organically bound tritium derived from diet – phase 2. Report to the Canadian nuclear safety commission, Contract no. 87055-8-5044/001/SS

    Google Scholar 

  168. Richardson R, Dunford DW (2003) A biochemical-based model for the dosimetry of dietary organically bound tritium. Health Phys 85(5):523–538

    Article  CAS  Google Scholar 

  169. Richardson RB, Dunford DW, Peterson SR (2001) Influence of gender differences in the carbon pool on dose factors for intakes of tritium and 14C-labelled compounds. Health Phys 81(3):302–312

    Article  CAS  Google Scholar 

  170. Komatsu K, Okamura Y, Sakamoto K (1990) Radiation dose to mouse liver cells from ingestion of tritiated food and water. Health Phys 58:625–629

    Article  CAS  Google Scholar 

  171. Müller WU (2008) Comment on the invited editorial ‘effectiveness of tritium beta particles’. J Res Pract 28:249–252

    Google Scholar 

  172. Müller WU (2008) Reply to the reply to comment on the invited editorial ‘effectiveness of tritium beta particles’. J Res Pract 28:423–426

    Google Scholar 

  173. Bridges BA (2008) Reply to comment on the invited editorial ‘effectiveness of tritium beta particles’. J Res Pract 28:249–252

    Google Scholar 

  174. Bridges BA (2008) A further reply. J Res Pract 28:423–426

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin Bundy .

Editor information

Editors and Affiliations

Units

Units

  • Bq: becquerel

  • cm: centimeter

  • d: day

  • g: gram

  • GBq: gigabecquerel

  • Gy: gray

  • h: hour

  • kBq: kilobecquerel

  • keV: kiloelectron volts

  • kg: kilogram

  • km2: kilometer squared

  • kV: kilovolt

  • kVcp: kilovolt constant potential

  • kVp: kilovolt peak

  • L: liter

  • MBq: megabequerel

  • m: meter

  • m2: meter squared

  • m3: meter cubed

  • mGy: milligray

  • mL: milliliter

  • mm: millimeter

  • mSv: millisievert

  • R: röntgen

  • Sv: sievert

  • μSv: microsievert

  • μm: micrometer

  • y: year

Abbreviations

AECL

Atomic Energy Canada Limited

AGIR

Advisory Group on Ionizing Radiation

AI

Alveolar-interstitial

BEIR

Biological Effects of Ionizing radiation

BW

Body weight

CF

Concentration fetus

CM

Concentration mother

CANDU

Canadian deuterium uranium

CERRIE

Committee Examining Radiation Risk from Internal Emitters

CI

Confidence interval

CNSC

Canadian Nuclear Safety Commission

CTH3

Tritiated methane

DAC

Derived air concentration

DDREF

Dose and dose rate effectiveness factor

DNA

Deoxyribonucleic acid

GI

Gastro-intestinal

H2O

Chemical symbol for water, also seen as HOH

HCNO

Hydrogen carbon nitrogen oxygen

HSE

Health and Safety Executive

HT

Tritiated gas

3HTdR

Tritiated thymidine

HTO

Tritiated water

ICRP

International Commission on Radiological Protection

ICRU

International Commission on Radiological Units and Measurements

LD

Lethal dose

LD50/30

Lethal dose that kills 50% of the population in 30 days

LDEF

Low dose effectiveness factor

LET

Linear energy transfer

N

Number

NCRP

National Council on Radiation Protection

NGS

Nuclear generating station

NPP

Nuclear power plant

OBT

Organically bound tritium

OH

Hydroxyl

OPG

Ontario Power Generation

OR

Odds ratio

PNM

Principal nutrient metabolic

PSL

Priority substance list

PWR

Pressurized water reactor

Q

Quality factor

RBE

Relative biological effectiveness

RBEMAX/M

Maximum relative biological effectiveness

REF

Radiation effectiveness factor

RR

Relative risk

SMR

Standardized mortality ratio

SSB

Single strand break

SSK

German Commission on Radiological Protection

Type F,M,S

Type fast, medium, slow, absorption rates

UK

United Kingdom

UKAEA

United Kingdom Atomic Energy Authority

UNSCEAR

United Nations Scientific Committee on the Effects of Atomic Radiation

wR

Radiation weighting factor

wT

Tissue weighting factor

χ2

Chi squared

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this entry

Cite this entry

Bundy, K., Thériault, B., Lane, R., Burtt, J., Thompson, P. (2012). Tritium , Health Effects and Dosimetry . In: Meyers, R.A. (eds) Encyclopedia of Sustainability Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0851-3_423

Download citation

Publish with us

Policies and ethics